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The aim of this study was to assess the degree of asthma control according to GINA criteria
during two different seasons in Spain.
An multicenter, longitudinal, epidemiological study with the participation of a sample of
physicians in Spain was conducted. Consecutive asthma patients, 18 years of age and older,
seeking primary and specialist care were included in the study. Patients were seen during
the winter and spring 2004 and were asked about asthma control according to GINA control
criteria (daytime and nighttime symptoms, asthma exacerbations, limitations of physical
activity, and visits to the emergency department) during the 4 weeks prior to the visit.
Control was defined according to daytime and nighttime symptoms.
A total of 614 patients participated in the study. The proportion of patients reporting
daytime symptoms ‘‘every day’’ or ‘‘most days’’ during the winter versus spring was 40.1%
vs. 23% ðPo0:01Þ; 26.9% vs. 14.1% presented symptoms at night ðPo0:01Þ; 11.5% vs. 8.3%
had severe exacerbations; 33.5% vs. 35.7% presented symptoms accompanying exercise,
and 9.4% vs. 4.3% ðPo0:01Þ had required emergency visits. The number of patients with
inadequate control was slightly higher in winter than in spring (74.4% vs. 71%) ðPo0:01Þ.
The most commonly prescribed treatment was ICS plus LABAs for both periods.Elsevier Ltd. All rights reserved.
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Table 1 Definition of asthma c
GINA
Daytime and nighttime symptom
Intermittent
Mild persistent
Moderate persistent
)
Severe persistent
A. Fueyo et al.920Asthma is poorly controlled in Spain and strategies are needed to improve management of
this illness.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Asthma is a chronic disease, common in developed coun-
tries, and a progressive increase in asthma has been
reported worldwide.1,2 Given the morbidity and mortality
associated with asthma, it is becoming an increasingly
serious public health concern.3,4
The European Community Respiratory Health Survey
(ECRHS), conducted between 1991 and 1993, examined the
prevalence of asthma in adults in 22 countries throughout
the world including Spain.5 According to this study, the mean
global prevalence of asthma was 4.5% (range 2.0–11.9%)6,7;
whereas in Spain tremendous geographical variability was
observed ranging from 5% in Galdakano to 14.5% in
Huelva.8,9
In an attempt to improve the quality of healthcare for
asthma sufferers, as well as to decrease burden of the
disease on public healthcare systems, the International
Global Initiative for Asthma (GINA) guidelines and the
Spanish National Guidelines for the Management of Asthma
(GEMA) have been established.10,11
Despite the theoretical consensus surrounding the man-
agement of asthma, several studies have shown that the
treatment recommendations for asthma published in the
guidelines are not always followed as would be ex-
pected.12–16 The Asthma Insights & Reality in Europe (AIRE)
Study, a multi-national, population-based telephone survey,
showed that 94.7% of all patients fail to achieve proper
control of their disease.12 An office-based study conducted
in Spain, the ASES Study, confirmed that the percentage of
patients who reported suffering symptoms more than once a
week at primary care and pneumologist office visits was 24%
and 32%, respectively.17 Despite these findings, recent data
indicate that the use of proper treatment, which would
include the combination of a long-acting b2 agonist and
inhaled corticosteroids (ICS) at the required doses and
duration, could improve asthma control.18 Climate changes
have been described among asthma precipitating fac-
tors19,20 and may increase the percentage of asthma
patients with poor asthma control.
The primary endpoint of this study was to determine the
level of asthma control in Spain and to assess the changes in
asthma control during two different seasons in Spain—win-
ter and spring. The main study hypothesis is that despiteontrol based on daytime and ni
Operational definit
s Asthma control
Good
Moderate
Poor
Poorprevious studies and guidelines, asthma control in Spain
remains limited.
Methods
This is an multicenter, longitudinal, epidemiological study
with retrospective data collection. Study participants
attended a total of two study visits, one in the winter and
the other one in the spring, in order to evaluate the degree
of asthma control during each period. According to expert
consensus, the distribution among allergists, pneumologists,
and primary care physicians was established so as to be
representative of the entire Spanish territory and applied
per autonomous community. Reliable data are not available
regarding the distribution of healthcare services in Spain
(primary care, allergology, and pneumology); hence, the
decision was made to base the results on an expert
consensus panel (approximately 45% primary care, 15%
allergology, and 40% pneumology). The study was approved
by an Ethics Committee and all the participants signed an
informed consent document.
Patients aged 18 years or older with a GINA-based
diagnosis of asthma for more than 1 year and no con-
comitant chronic respiratory disease were consecutively
included in the study that contemplated two study visits.
The first one in the winter during the first 2 weeks in March,
2004; the same patients were seen again in the spring during
the first half of May, 2004.
Sociodemographic data (age, gender, smoking status) and
clinical variables (years since asthma diagnosis, allergic and
non-allergic asthma, asthma severity, concomitant disease,
and asthma therapy) were collected. Allergic asthma was
defined by a positive allergy test, independently of IgE
levels.
Subjects answered questions about the presence of any of
the following GINA control criteria in the preceding 4 weeks:
daytime symptoms, nighttime symptoms, asthma exacerba-
tions (defined as severe, sudden episodes of coughing,
wheezing, or difficulty breathing), limitations of physical
activity, and emergency visits.
An operational definition of asthma control based only on
the frequency of daytime and nighttime symptoms accord-
ing to GINA severity criteria was agreed upon (Table 1) and
applied to study patients in the statistical analysis phase.ghttime symptoms following GINA clinical severity criteria.
ion
Asthma control
Good)
Inadequate
Inadequate
Inadequate
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Table 2 Patient baseline sociodemographic and clinical
characteristics.
Baseline characteristics ðn ¼ 594Þ N (%)
Age, years (SD) 49.6 (18.1)
Gender, female 380 (64)
Smoking status
Smoker 66 (11.1)
Ex-smoker 150 (25.3)
Non-smoker 376 (63.5)
History of asthma
o 5 years 120 (20.3)
5–9 years 158 (26.8)
410 years 312 (52.9)
Type of asthma
Allergic 326 (55.2)
Non-allergic 211 (35.7)
Unknown 54 (9.1)
Concomitant disease
Allergic rhinitis 289 (48.7)
Conjunctivitis 149 (25.1)
Dermatitis 74 (12.5)
Severity of asthma (GINA)
Intermittent 141 (23.9)
Mild persistent 199 (33.8)
Moderate persistent 196 (33.3)
Severe persistent 53 (9.0)
Reason for visit
Regular check-up 408 (69.3)
Increase in symptoms 65 (11)
Need for medication 58 (9.8)
Other 58 (9.8)
Asthma treatment
No therapy 7 (1.2)
Monotherapy 193 (32.5)
SABA 59 (9.9)
ICS 91 (15.3)
LABA 34 (5.7)
LRA 9 (1.5)
Combined therapy 372 (62.6)
ICS+LABA 299 (50.3)
ICS+LABA+LRA 73 (12.3)
Other regimensy 22 (3.7)
Oral corticosteroids 33 (5.6)
Immunotherapy 13 (2.2)
Missing data: smoking status (2), history of asthma (4), type
of asthma (3), concomitant disease (1), asthma severity (5),
and reason for visit (5).
At the time of diagnosis.
yOther regimens included: theophylline (5), anticholiner-
gics (5), or other atypical combinations such as ICS+LRAs (11)
and LABAs+LRAs (1).
Asthma control in Spain 921The following categories were defined irrespective of the
treatment patients were receiving at the time: ‘‘good
control’’, when the severity of symptoms was intermittent
during the day and at night; ‘‘moderate control’’, when
symptom severity was mild, and ‘‘poor control’’ when there
were moderate or severe symptoms during the day and at
night. Patients were defined as controlled if they presented
‘‘good control’’ of their asthma and as inadequately
controlled when they had ‘‘moderate control’’ or ‘‘poor
control’’. Definition of intermittent, mild, and moderate, or
severe were defined according to the GINA classification in
terms of nighttime and daytime symptoms.
The asthma treatment pattern variable was categorized
into the following groups: (1) no therapy; (2) monotherapy:
short-acting b2 adrenergics (SABAs), long-acting b2 adrener-
gics (LABAs), ICS, or leukotriene receptor antagonists
(LRAs); (3) combined treatment: ICS+LABAs, ICS+LABAs+L-
RAs, and (4) other regimes that included primarily treat-
ment with theophylline and anticholinergics, or other
combinations such as ICS+LRAs and LABAs+LRAs. Immu-
notherapy and oral corticosteroid use were classified as
independent dichotomous variables.
A sample size of 547 patients was calculated in order to
be able to estimate that 35% of the asthmatic patients had
good asthma control at the follow-up visit with a four-point
level of accuracy and significance level of 0.05.16
Statistical analysis
Student’s t-test or w2-test was used when appropriate to
compare continuous or categorical variables between
independent groups. McNemar’s test for paired data was
used to compare GINA control criteria between seasons.
The SPSS software package (version 10.1.3 for Windows)
was used for data analysis. The level of statistical
significance was defined as an alpha value o0.05.
Results
Sixty-seven physicians from all over Spain participated in
the study: 31 (46%) primary care physicians, 26 (39%)
pneumologists, and 10 (15%) allergists. A total of 614
patients were recruited in winter, with an average of eight
patients per investigator. A total of six patients in winter
and six in spring had not completed the asthma control
information and were excluded from the final analysis.
Another eight patients were lost to follow-up at the spring
visit. A 594-patient sample was finally analyzed. No
differences were found upon comparison of patients
excluded from the final analysis with non-excluded patients.
Baseline sociodemographic and clinical characteristics are
presented in Table 2. Mean patient age was 49.6 years and
there was a greater proportion of females versus males
(64%). At the time of asthma diagnosis, most patients were
non-smokers (63.5%), had a history of asthma of more than
10 years (52.9%), and presented mild and moderate
persistent asthma (33% each category). Asthma was allergic
in origin in 55.2% of the patients. The most frequently
reported concomitant disease was allergic rhinitis (48.7%).
At baseline, most patients (50.3%) were on combined
asthma therapy consisting of ICS and LABAs.
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Figure 1 Asthma control in Spain according to frequency of
daytime and nighttime symptoms in two seasonal periods.
Control was defined based on daytime and nighttime symptoms
according to GINA severity criteria: good ¼ intermittent asth-
ma; moderate ¼ mild persistent asthma; poor ¼ moderate to
severe persistent asthma.*Po0.01.
A. Fueyo et al.922Asthma control according to season
Patients’ responses to five GINA control criteria correspond-
ing to the 4 weeks prior to the visit for the two seasons are
shown in Table 3. Daytime or nighttime symptoms, asthma
exacerbations, limitations of physical activity, and emer-
gency visits. The most frequently reported symptoms in
winter and spring were daytime symptoms and limitations of
physical activity. Statistically significant differences in the
percentage of patients with some degree of symptoms
between periods were not detected. ‘‘Every day’’ or ‘‘most
days’’ daytime and nighttime symptoms were significantly
higher in winter than in spring (40.1% vs. 23% and 26.9% vs.
14.1%, respectively), whereas no seasonal differences were
found for limitations of physical activity ‘‘every day’’ or
‘‘most days’’ (33.5% vs. 35.7%, respectively). Although the
proportion of patients reporting asthma exacerbations
‘‘every day’’ or ‘‘most days’’ was higher in winter, the
differences between seasons were not statistically signifi-
cant (11.5% vs. 8.3%, respectively). The proportion of
patients requiring visits to the emergency room at anytime
was significantly higher in winter than in spring, 9.4% vs.
4.3%, respectively. When any symptom frequency is taken
into account (first and third column of Table 3), the
proportion of patients with symptoms is consistently greater
in winter.
The percentages of patients defined as having a good
control, moderate control, and poor control are shown in
Fig. 1. A slightly larger proportion of patients presented
inadequate control (moderate or poor) in the winter
compared to the spring, 74.4% vs. 71%, respectively
ðPo0:01Þ. The proportion of patients reporting poor control
significantly decreased in the spring, 34.7% vs. 21%,
respectively ðPo0:05Þ.
In 15.8% of the patients, the asthma treatment pattern
had been modified in the interval between both study visits.Table 3 Asthma control over the 4 weeks preceding study visi
Symptoms Winter
% with symptoms % high f
How often have you had
symptoms during the day?
70.9 40.1
How often have you had
symptoms at night?
47.5 26.9
How often have you had a
severe asthma attack/
exacerbation?
25.1 11.5
How often have you suffered
from any symptom during
physical activity?
69.2 33.5
How often have you gone to
the emergency room for
your asthma?
9.4
Proportion of study patients describing any symptom frequency o
yProportion of patients with symptoms ‘‘every day’’ or ‘‘most days’’
(positive response in previous column).
zPo0.01.Given the huge diversity of prescribed treatments, the
percentage of patients in whom treatment had been
changed was not analyzed because the figures for each
group would have been too low to achieve significance.Asthma control-related variables
Bivariate analysis revealed that relations between asthma
control and sociodemographic (age and gender), clinical
(history of asthma, type of asthma, and asthma severity) or
smoking status variables lacked statistical significance.
Asthma control was only seen to be related to the presencets according to GINA criteria.
Spring
requencyy % with symptoms % high frequencyy
67.2 23.0z
44.5 14.1z
20.9 8.3
66.0 35.7
4.3z
r with at least one visit to the emergency department.
calculated over the total number of patients with each symptom
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Asthma control in Spain 923of certain specific diseases such as depression ðPo0:01Þ,
diabetes ðPo0:01Þ, or cardiovascular diseases ðPo0:05Þ, and
to the reason for the visit ðPo0:01Þ and treatment pattern
ðPo0:05Þ.Discussion
Despite a commonly held view that asthma control can be
attained in most patients, different studies have shown that
the objectives for good control proposed by international
reference guidelines are still far from being met.12–16
To our knowledge, this is the first paper that examines
asthma control in the Spanish population by personally
interviewing a sample of patients who sought care from any
of three different medical specialties: primary care physi-
cians, pneumologists, and allergists. Given that these
patients were seen periodically by clinicians, one would
have expected to see better disease control than what has
been observed in studies such as the AIRE Study, where
asthmatic patients participated in a telephone survey of the
general population.12 Nonetheless, our findings confirm a
degree of inadequate asthma control similar to that of
previous studies.12–16
Combining the frequency and severity of daytime and
nighttime symptoms in the 4 weeks prior to the visits, only
25.6% of the patients was seen to have good control of their
asthma at the winter visit. While these figures improved in
the spring, they remained well below the recommended
levels of control. By interviewing the same patients on two
different occasions, the intervention itself may have
improved the outcomes; thus, these results should be
interpreted with caution. However, should this supposition
be true, it would be worth hypothesizing as to what
educational, reminder, or self-monitoring interventions
might be carried out that could enhance control of this
illness.
Other studies have assessed asthma control in different
settings. In the AIRE Study, subjects were randomly selected
from the general population by means of a telephone survey
and asthma control was defined as meeting GINA criteria for
‘‘good control’’, ‘‘moderate control’’, and ‘‘poor control’’,
depending on whether 0–1, 2–3, or 4–5 of the GINA criteria
were met, respectively.12 Of the 2050 adults with asthma
who finally participated in the study, 35% of the cases were
seen to have ‘‘good’’ disease control; 40% had ‘‘moderate’’
control, and in the remaining 25%, control was ‘‘poor’’. In
the ASES Study comparing asthma management by pneumol-
ogists with primary healthcare physicians in Spain, Lo´pez-
Vin˜a et al.17 found that more than 25% of the participants
reported nighttime symptoms on more than two occasions
per month and 24% had visited the emergency room in the
previous year. Despite differences in the definition of
control, these data reconfirm the unexpectedly low level
of adequate asthma control in different settings.
This study was not designed to examine the reasons for
the poor asthma control reported, although previous studies
have shown that despite the fairly explicit current treat-
ment guidelines for managing the disease, a high percentage
of physicians do not follow the established recommenda-
tions.21 A recent study has demonstrated that when
treatment is stepped-up appropriately and maintained forlong enough, proper control can be achieved in an important
percentage of patients.22 The fact that some studies have
also shown that patients used their medication inappropri-
ately, even when presenting moderate or severe asthma
symptoms is of even greater concern.12–16 Hence, the dual
effect of failure to comply with recommendations on the
part of the physician and poor patient adherence to
treatment might be considered to be the leading cause of
poor disease control.12–16 On the other hand, although
recent studies have shown that with appropriate treatment
it is possible to reach the objectives purported by the
guidelines,18 neither patients nor physicians are very
demanding when it comes to establishing to what extent
these objectives should be met and both are willing to
believe that some symptoms are simply part of the disease.
In a study conducted in the UK, Jones et al.23 included 1031
asthmatic patients, 51% of whom considered their health
status to be good and accepted certain limitations in their
daily lives due to their disease as normal. Data compiled by
the Spanish group of the European study on asthma showed
that more than half of the people with asthma stated either
that they did not have or had not had asthma and
approximately one-third were not treated for the disease.8
Another recent study published by Bellamy and Harris24,25
examined patients’ and physicians’ opinions regarding the
level of disease control and showed that most patients (82%)
considered that their asthma was not controlled and most
physicians (70%) believed that their patients accepted the
symptoms of the disease as normal and were well adapted to
their daily routines.
This study has a number of limitations. First, there is the
issue regarding sample representativity. Reliable data are
not available with respect to the distribution of healthcare
areas in Spain; consequently, it was decided to base the
results on an expert consensus panel. Nonetheless, a
homogeneous office distribution was applied in the different
Autonomous Communities despite the fact that there might
be geographical differences in terms of healthcare re-
sources. Therefore, the results observed may not be
representative of the different geographical regions. Sec-
ond, lung function was not recorded and asthma severity
was recorded retrospectively at the time of diagnosis. It is
possible that these criteria were not accurate to define the
current severity of illness and this may explain why severity
was not associated with disease control. Third, an opera-
tional definition was used to define asthma control based on
daytime and nighttime symptoms. This definition could have
introduced some misclassification leading to either an over-
or underestimation of the effect size. Nonetheless, daytime
and nighttime symptoms were the two only clinical criteria
that showed statistically significant differences between
winter and spring. Therefore, we speculate that these two
criteria alone are good indicators of asthma control and
suggest that using such an easy clinical indicator of control
may make it easier to manage asthma in routine, daily
practice. Finally, the seasons were selected by convenience
and no objective weather parameters such as temperature,
humidity, wind, or rainfall were collected; moreover, pollen
count data is unavailable. As a result, the interaction
between allergens, weather, and asthma control could not
be evaluated and hence, it cannot be ruled out that the
seasonal changes detected in the study were largely
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A. Fueyo et al.924determined by the study intervention. However, the homo-
geneous trend towards a higher proportion of patients with
symptoms, exacerbations, and emergency room visits during
the winter confirms our results.
In summary, the findings of this study show that asthma
control in Spain remains very far from the long-term
objectives established by GINA. Improving asthma manage-
ment together with greater patient awareness in complying
with medical recommendations are important issues if
control of the disease is to be improved.Acknowledgments
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